Effects of timolol on MYOC, OPTN, and WDR36 RNA levels.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  A M A Archives of Ophthalmology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archopht.126.1.86PMID 18195223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression profile prioritization of positional candidate glaucoma genes: the GLC1C locus.

  2007cited by this paper
• Temperature sensitive secretion of mutant myocilins.

  2006cited by this paper
• Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue.

  2006cited by this paper
• Baseline Factors Associated With IOP Mean and Variability During Long–Term Treatment for Newly–Diagnosed Open–Angle Glaucoma

  2006cited by this paper
• Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure.

  2006cited by this paper
• The number of people with glaucoma worldwide in 2010 and 2020

  2006cited by this paper
• PREDICTIVE FACTORS FOR GLAUCOMATOUS VISUAL FIELD PROGRESSION IN THE ADVANCED GLAUCOMA INTERVENTION STUDY

  2005cited by this paper
• Mutations including the promoter region of myocilin/TIGR gene

  2005cited by this paper
• Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.

  2005cited by this paper
• Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma.

  2005cited by this paper
• Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma

  2004cited by this paper
• Factors for progression and glaucoma treatment: The Early Manifest Glaucoma Trial

  2004cited by this paper
• Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

  2004cited by this paper
• Polymorphisms in the Myocilin Promoter Unrelated to the Risk and Severity of Primary Open-Angle Glaucoma

  2004cited by this paper
• Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants.

  2004cited by this paper
• Donor corneoscleral buttons: a new source of trabecular meshwork for research.

  2003cited by this paper
• Association of the myocilin mt.1 promoter variant with the worsening of glaucomatous disease over time

  2003cited by this paper
• Changes in myocardial gene expression associated with β-blocker therapy in patients with chronic heart failure

  2003cited by this paper
• Pooled-Data Analysis of Three Randomized, Double-Masked, Six-Month Studies Comparing Intraocular Pressure-Reducing Effects of Latanoprost and Timolol in Patients With Ocular Hypertension

  2003cited by this paper
• The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

  2002cited by this paper
• Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure.

  2002cited by this paper
• How clinical trial results are changing our thinking about target pressures

  2002cited by this paper
• Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin

  2002cited by this paper
• Forskolin upregulation of NOS I protein expression in porcine ciliary processes: a new aspect of aqueous humor regulation

  2002cited by this paper
• Variations in the myocilin gene in patients with open-angle glaucoma.

  2002cited by this paper
• Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action.

  2001cited by this paper
• Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open‐angle glaucoma

  2001cited by this paper
• Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva.

  2001cited by this paper
• Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function

  2001cited by this paper
• Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing Action

  2001cited by this paper
• Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC.

  2001cited by this paper
• Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Mietz H, ∗ Schlotzer-Schrehardt U, Strassfeld C, Krieglstein GK. Invest Ophthalmol Vis Sci 2001;42:679–687.

  2001cited by this paper
• Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma

  2000cited by this paper
• Subtype specific downregulation of thyroid hormone receptor mRNA by beta-adrenoreceptor blockade in the myocardium.

  2000cited by this paper
• Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma.

  2000cited by this paper
• Regulation of human myocilin/TIGR gene transcription in trabecular meshwork cells and astrocytes: role of upstream stimulatory factor

  2000cited by this paper
• TIGR/MYOC proximal promoter GT‐repeat polymorphism is not associated with myopia

  2000cited by this paper
• Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells

  2000cited by this paper
• A cellular assay distinguishes normal and mutant TIGR/myocilin protein.

  1999cited by this paper
• Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork.

  1998cited by this paper
• Gene Structure and Properties of TIGR, an Olfactomedin-related Glycoprotein Cloned from Glucocorticoid-induced Trabecular Meshwork Cells*

  1998cited by this paper
• Apoptosis and morphologic changes in drug-treated trabecular meshwork cells in vitro.

  1998cited by this paper
• β-Adrenergic agonist-induced nitrite production in isolated pig ciliary processes

  1998cited by this paper
• Adrenergic Drug Effects on Cyclic AMP in Cultured Human Trabecular Meshwork Cells

  1998cited by this paper
• Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product.

  1997cited by this paper
• Identification of a Gene That Causes Primary Open Angle Glaucoma

  1997cited by this paper
• Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents.

  1996cited by this paper
• Number of people with glaucoma worldwide.

  1996cited by this paper
• Cultured human trabecular meshwork cells express functional alpha 2A adrenergic receptors.

  1996cited by this paper
• Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro.

  1993cited by this paper
• Genetic linkage of familial open angle glaucoma to chromosome 1q21–q31

  1993cited by this paper
• Optisol corneal storage medium.

  1991cited by this paper
• Beta Adrenergic Binding Sites in the Human Eye: An Autoradiographic Study

  1990cited by this paper
• Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork.

  1989cited by this paper
• Penetration of timolol eye drops into human aqueous humour: the first hour.

  1985cited by this paper
• The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

  1978cited by this paper
• The mechanism of timolol in lowering intraocular pressure. In the normal eye.

  1978cited by this paper

• Myocilin Levels in Primary Open-angle Glaucoma and Pseudoexfoliation Glaucoma Human Aqueous Humor

  2010cites this paper
• Glaucoma-associated myocilin: a better understanding but much more to learn.

  2009cites this paper